Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma

Bone Marrow Transplantation volume 27, pages 663–666 (2001)Cite this article

Abstract

A 41-year-old male with IgG kappa multiple myeloma is described. He developed a free gamma heavy chain without an accompanying light chain following high-dose chemotherapy and autologous peripheral blood stem cell transplantation. The free gamma heavy chain was detected in serum and urine specimens 2 months after transplant, and eventually evolved into an IgG kappa monoclonal protein with electrophoretic properties similar to the original myeloma protein. Although the origin of the free gamma heavy chain remains uncertain, it was most likely related to the underlying plasma cell malignancy and, therefore, was an early sign of disease relapse. Bone Marrow Transplantation (2001) 27, 663–666.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Landis SH, Murray T, Bolden S et al. Cancer statistics 1999 CA Cancer J Clin 1999 49: 8–31

    Article  CAS  Google Scholar 

  2. Boccadoro M, Peleri A . Diagnosis, prognosis, and standard treatment of multiple myeloma Hematol Oncol Clin North Am 1997 11: 111–131

    Article  CAS  Google Scholar 

  3. Barlogie B, Jagannath S, Desikan KR et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma Blood 1999 93: 55–65

    CAS  Google Scholar 

  4. Zent CS, Wilson CS, Tricot G et al. Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation Blood 1998 91: 3518–3523

    CAS  Google Scholar 

  5. Hovenga S, de Wolf JThM, Guikema JEJ et al. Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation Bone Marrow Transplant 2000 25: 723–728.

    Article  CAS  Google Scholar 

  6. Guikema JEJ, Vellenga E, Veeneman JM et al. Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation Br J Haematol 1999 104: 748–754

    Article  CAS  Google Scholar 

  7. Preud'Homme JL, Hurez D, Danon F et al. Intracytoplasmic and surface-bound immunoglobulins in ‘nonsecretory’ and Bence–Jones myeloma Clin Exp Immunol 1976 25: 428–436

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Preud'Homme JL, Brouet JC, Seligmann M . Cellular immunoglobulins in human γ- and α-heavy chain diseases Clin Exp Immunol 1979 37: 283–291

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Fermand JP, Brouet JC . Heavy-chain diseases Hematol Oncol Clin North Am 1999 13: 1281–1294

    Article  CAS  Google Scholar 

  10. Fermand JP, Brouet JC, Danon F et al. Gamma heavy chain ‘disease’: heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature Medicine 1989 68: 321–335

    Article  CAS  Google Scholar 

  11. Tricot G, Barlogie B, Jagannath S et al. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosomes 13 or abnormalities involving 11q and not with other karyotype abnormalities Blood 1995 86: 4250–4256

    CAS  PubMed  Google Scholar 

  12. Rajkumar SV, Greipp PR . Prognostic factors in multiple myeloma Hematol Oncol Clin North Am 1999 13: 1295–1314

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, UCLA Medical Center, Los Angeles, CA, USA

    AW Butch

  2. Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, AK, USA

    AW Butch, A Badros, KR Desikan & NC Munshi

  3. South Central Arkansas Veterans Health Care System, Little Rock, AK, USA

    NC Munshi

Authors
  1. AW Butch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Badros
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. KR Desikan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. NC Munshi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Butch, A., Badros, A., Desikan, K. et al. Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma. Bone Marrow Transplant 27, 663–666 (2001). https://doi.org/10.1038/sj.bmt.1702850

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702850

Keywords

Search

Advanced search

Quick links